BlackRock’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,850,498
Closed -$52.6M 5074
2020
Q1
$52.6M Sell
13,850,498
-438,426
-3% -$1.67M ﹤0.01% 1997
2019
Q4
$72.7M Buy
14,288,924
+567,969
+4% +$2.89M ﹤0.01% 2128
2019
Q3
$69.4M Sell
13,720,955
-21,719
-0.2% -$110K ﹤0.01% 2086
2019
Q2
$84.8M Buy
13,742,674
+209,687
+2% +$1.29M ﹤0.01% 2006
2019
Q1
$62.8M Buy
13,532,987
+2,224
+0% +$10.3K ﹤0.01% 2140
2018
Q4
$56.8M Buy
13,530,763
+237,520
+2% +$998K ﹤0.01% 2155
2018
Q3
$83.3M Buy
13,293,243
+1,902,006
+17% +$11.9M ﹤0.01% 2075
2018
Q2
$91.6M Buy
11,391,237
+1,401,564
+14% +$11.3M ﹤0.01% 1992
2018
Q1
$74.5M Sell
9,989,673
-7,068
-0.1% -$52.7K ﹤0.01% 2022
2017
Q4
$59.5M Buy
9,996,741
+202,932
+2% +$1.21M ﹤0.01% 2163
2017
Q3
$72.1M Buy
9,793,809
+203,989
+2% +$1.5M ﹤0.01% 2043
2017
Q2
$65.1M Buy
9,589,820
+66,767
+0.7% +$453K ﹤0.01% 2063
2017
Q1
$89.9M Buy
9,523,053
+9,516,686
+149,469% +$89.8M ﹤0.01% 1845
2016
Q4
$55K Sell
6,367
-236
-4% -$2.04K ﹤0.01% 2827
2016
Q3
$42K Buy
6,603
+728
+12% +$4.63K ﹤0.01% 2990
2016
Q2
$24K Buy
5,875
+1,696
+41% +$6.93K ﹤0.01% 3181
2016
Q1
$19K Buy
4,179
+2,650
+173% +$12K ﹤0.01% 2834
2015
Q4
$9K Hold
1,529
﹤0.01% 2920
2015
Q3
$9K Hold
1,529
﹤0.01% 2776
2015
Q2
$11K Sell
1,529
-389
-20% -$2.8K ﹤0.01% 2703
2015
Q1
$11K Hold
1,918
﹤0.01% 2665
2014
Q4
$15K Hold
1,918
﹤0.01% 2494
2014
Q3
$10K Hold
1,918
﹤0.01% 2703
2014
Q2
$8K Sell
1,918
-63
-3% -$263 ﹤0.01% 2911
2014
Q1
$8K Buy
1,981
+484
+32% +$1.96K ﹤0.01% 2856
2013
Q4
$8K Hold
1,497
﹤0.01% 2845
2013
Q3
$8K Hold
1,497
﹤0.01% 2791
2013
Q2
$7K Buy
+1,497
New +$7K ﹤0.01% 2882